Viewing Company
Company Name:
VICAPSYS LIFE SCIENCES, INC.
CIK:
1468639
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2020-05-15
Last Filing Date:
2025-01-10
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2020-01-01 | 2020-03-31 | CY2020Q1 | 2020-05-15 | 0001493152-20-009028 | $ 17,483,283 | View |
| 2020-04-01 | 2020-06-30 | CY2019Q2 | 2021-09-09 | 0001493152-21-022270 | $ 17,483,283 | View |
| 2020-01-01 | 2020-12-31 | CY2019 | 2021-09-17 | 0001493152-21-022984 | $ 17,483,283 | View |
| 2021-07-01 | 2021-09-30 | CY2021Q3 | 2021-11-12 | 0001493152-21-027976 | $ 17,507,283 | View |
| 2020-07-01 | 2020-09-30 | CY2019Q3 | 2021-09-13 | 0001493152-21-022517 | $ 17,483,283 | View |
| 2021-04-01 | 2021-06-30 | CY2021Q2 | 2021-09-20 | 0001493152-21-023189 | $ 17,507,283 | View |
| 2021-01-01 | 2021-03-31 | CY2020Q1 | 2021-09-20 | 0001493152-21-023170 | $ 17,496,083 | View |
| 2021-01-01 | 2021-12-31 | CY2020Q4I | 2022-03-16 | 0001493152-22-006994 | $ 11,067,281 | View |
| 2022-03-13 | 2022-03-31 | CY2022Q1I | 2022-05-13 | 0001493152-22-013375 | $ 1 | View |
| 2024-01-01 | 2024-06-30 | CY2024Q2 | 2025-01-10 | 0001493152-25-001776 | $ 6,166 | View |
| 2024-01-01 | 2024-09-30 | CY2024Q3I | 2025-01-10 | 0001493152-25-001779 | $ 55,000 | View |
| 2022-01-01 | 2022-06-30 | CY2022Q2I | 2022-08-16 | 0001493152-22-023207 | $ 78,693 | View |
| 2022-07-01 | 2022-09-30 | CY2022Q3I | 2022-11-21 | 0001493152-22-033024 | $ 50,000 | View |
| 2024-01-01 | 2024-03-31 | CY2024Q1 | 2025-01-10 | 0001493152-25-001743 | $ -6,167 | View |
| 2021-01-01 | 2021-12-31 | CY2021 | 2023-04-14 | 0001493152-23-012267 | $ 100,000 | View |
| 2023-01-01 | 2023-03-31 | CY2023Q1I | 2023-05-15 | 0001493152-23-017138 | $ 718,228 | View |
| 2023-01-01 | 2023-12-31 | CY2023 | 2024-10-21 | 0001493152-24-041809 | $ 83,526 | View |
| 2023-01-01 | 2023-06-30 | CY2023Q2I | 2023-08-14 | 0001493152-23-028151 | $ 54,230 | View |
| 2023-07-01 | 2023-09-30 | CY2023Q3 | 2023-11-14 | 0001493152-23-040951 | $ 9,954 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| us-gaap | Finite-Lived Patents, Gross | Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights. | View |
| us-gaap | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. | View |
| us-gaap | Disposal Group, Including Discontinued Operation, Revenue | Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation. | View |
| us-gaap | Due to Related Parties | Carrying amount as of the balance sheet date of obligations due all related parties. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| dei | Entity Listing, Par Value Per Share | The par value per share of security quoted in same currency as Trading currency. Example: '0.01'. | View |
| us-gaap | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accounts Payable, Related Parties, Current | Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accrued Salaries, Current | Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Additional Paid in Capital | Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. | View |
| us-gaap | Amortization | The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. | View |
| us-gaap | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net | Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP). | View |
| us-gaap | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash Equivalents, at Carrying Value | Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash Provided by (Used in) Financing Activities, Discontinued Operations | Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Cash Provided by (Used in) Operating Activities, Discontinued Operations | Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | View |
| us-gaap | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Contract with Customer, Liability, Revenue Recognized | Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. | View |
| us-gaap | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic and Diluted Share | Per basic and diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation, when the per share amount is the same. | View |
| us-gaap | Disposal Group, Including Discontinued Operation, Accrued Liabilities | Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of. | View |
| us-gaap | Disposal Group, Including Discontinued Operation, General and Administrative Expense | Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation. | View |
| us-gaap | Disposal Group, Including Discontinued Operation, Operating Expense | Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation. | View |
| us-gaap | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | Percentage of domestic federal statutory tax rate applicable to pretax income (loss). | View |
| us-gaap | Equity Method Investment, Ownership Percentage | The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. | View |
| us-gaap | Finite-Lived Intangible Assets, Accumulated Amortization | Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Year One | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year. | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Year Five | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Year Four | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Year Three | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Finite-Lived Intangible Asset, Expected Amortization, Year Two | Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Gain (Loss) on Investments | Amount of realized and unrealized gain (loss) on investment. | View |
| us-gaap | Gain (Loss) on Sale of Investments | The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | View |
| us-gaap | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. | View |
| us-gaap | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. | View |
| us-gaap | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. | View |
| us-gaap | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. | View |
| us-gaap | Increase (Decrease) in Prepaid Expense | The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. | View |
| us-gaap | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. | View |
| us-gaap | Operating Leases, Rent Expense | Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Net Income (Loss) Available to Common Stockholders, Basic | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. | View |
| us-gaap | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Operating Loss Carryforwards | Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. | View |
| us-gaap | Other Income | Amount of revenue and income classified as other. | View |
| us-gaap | Payments for Rent | Cash payments to lessor's for use of assets under operating leases. | View |
| us-gaap | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. | View |
| us-gaap | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | View |
| us-gaap | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Prepaid Expense, Noncurrent | Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. | View |
| us-gaap | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. | View |
| us-gaap | Proceeds from Issuance or Sale of Equity | The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. | View |
| us-gaap | Proceeds from Sale of Equity Method Investments | The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. | View |
| us-gaap | Professional Fees | A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. | View |
| us-gaap | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | View |
| us-gaap | Retained Earnings (Accumulated Deficit) | The cumulative amount of the reporting entity's undistributed earnings or deficit. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | The risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Gross number of share options (or share units) granted during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Number of options outstanding, including both vested and non-vested options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. | View |
| us-gaap | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | View |
| us-gaap | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. | View |
| us-gaap | Transfer to Investments | Value of investments transferred to the entity's investments in noncash transactions. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic and Diluted | Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | View |
| us-gaap | Other Nonoperating Income | Amount of income related to nonoperating activities, classified as other. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. | View |
| us-gaap | Shares, Issued | Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. | View |
| us-gaap | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. | View |
| us-gaap | Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units | Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of stock options or restrictive stock units (RSUs). | View |
| us-gaap | Conversion of Stock, Shares Issued | "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. | View |
| us-gaap | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method. | View |
| us-gaap | Royalty Expense | Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. | View |
| us-gaap | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. | View |
| us-gaap | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Other | Amount of other increase (decrease) in additional paid in capital (APIC). | View |
| us-gaap | Class of Warrant or Right, Exercise Price of Warrants or Rights | Exercise price per share or per unit of warrants or rights outstanding. | View |
| us-gaap | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | Amount of cost not yet recognized for nonvested award under share-based payment arrangement. | View |
| us-gaap | Preferred Stock Dividends and Other Adjustments | The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders. | View |
| us-gaap | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | Number of non-vested options outstanding. | View |
| us-gaap | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. | View |
| us-gaap | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. | View |
| us-gaap | Deferred Offering Costs | Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. | View |
| us-gaap | Goodwill, Impairment Loss | Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. | View |
| us-gaap | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. | View |
| us-gaap | Convertible Notes Payable, Current | Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. | View |
| us-gaap | Debt Instrument, Fair Value Disclosure | Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable. | View |
| us-gaap | Debt Instrument, Fee Amount | Amount of the fee that accompanies borrowing money under the debt instrument. | View |
| us-gaap | Income Taxes Paid, Net | The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes. | View |
| us-gaap | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. | View |
| us-gaap | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. | View |
| us-gaap | Proceeds from Notes Payable | The cash inflow from a borrowing supported by a written promise to pay an obligation. | View |
| us-gaap | Proceeds from Other Short-term Debt | Amount of cash inflow from short-term debt classified as other. | View |
| us-gaap | Short-term Debt | Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. | View |
| us-gaap | Interest Expense | Amount of the cost of borrowed funds accounted for as interest expense. | View |
| us-gaap | Amortization of Debt Issuance Costs and Discounts | Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. | View |
| us-gaap | Cash, FDIC Insured Amount | The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. | View |
| us-gaap | Debt Conversion, Converted Instrument, Shares Issued | "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or payments in the period." | View |
| us-gaap | Debt Instrument, Annual Principal Payment | Amount of the total principal payments made during the annual reporting period. | View |
| us-gaap | Debt Instrument, Face Amount | Face (par) amount of debt instrument at time of issuance. | View |
| us-gaap | Interest Expense, Debt | Amount of the cost of borrowed funds accounted for as interest expense for debt. | View |
| us-gaap | 317212 | None | View |
| us-gaap | Proceeds from (Repayments of) Notes Payable | Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation. | View |
| us-gaap | Stock Issued | The fair value of stock issued in noncash financing activities. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. | View |
| us-gaap | Gain (Loss) on Extinguishment of Debt | Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. | View |
| us-gaap | Increase (Decrease) in Notes Payable, Current | The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes. | View |
| us-gaap | Repayments of Short-term Debt | The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. | View |
| us-gaap | Proceeds from Convertible Debt | The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. | View |
| us-gaap | Short-term Bank Loans and Notes Payable | Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer. | View |
| us-gaap | Short-term Non-bank Loans and Notes Payable | Amount of borrowings from a creditor other than a bank with a maturity within one year or operating cycle, if longer. | View |
| us-gaap | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. | View |
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Earnings Per Share, Basic and Diluted | The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. | View |
| us-gaap | Salary and Wage, Officer, Excluding Cost of Good and Service Sold | Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. | View |
| us-gaap | Operating Loss Carryforwards, Valuation Allowance | The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Research and Development Expense | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| us-gaap | Net Income (Loss) Available to Common Stockholders, Diluted | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. | View |
| us-gaap | Increase (Decrease) in Accounts Payable, Related Parties | The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. | View |
| us-gaap | Increase (Decrease) in Accounts Payable, Trade | Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. | View |
| us-gaap | Income (Loss) from Equity Method Investments | Amount of income (loss) for proportionate share of equity method investee's income (loss). | View |
| us-gaap | Accounts Payable, Trade, Current | Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Amortization of Debt Discount (Premium) | Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Short-term Debt | View |
| Interest Expense | View |
| Earnings Per Share, Diluted | View |
| Accounts Payable, Current | View |
| Accounts Payable, Related Parties, Current | View |
| Accrued Salaries, Current | View |
| Additional Paid in Capital | View |
| Amortization | View |
| Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net | View |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | View |
| Assets | View |
| Assets, Current | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | View |
| Cash Equivalents, at Carrying Value | View |
| Cash Provided by (Used in) Financing Activities, Discontinued Operations | View |
| Cash Provided by (Used in) Operating Activities, Discontinued Operations | View |
| Common Stock, Par or Stated Value Per Share | View |
| Common Stock, Shares Authorized | View |
| Common Stock, Shares, Issued | View |
| Common Stock, Shares, Outstanding | View |
| Common Stock, Value, Issued | View |
| Contract with Customer, Liability, Revenue Recognized | View |
| Deferred Tax Assets, Operating Loss Carryforwards | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Depreciation | View |
| Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic and Diluted Share | View |
| Disposal Group, Including Discontinued Operation, Accrued Liabilities | View |
| Disposal Group, Including Discontinued Operation, General and Administrative Expense | View |
| Disposal Group, Including Discontinued Operation, Operating Expense | View |
| Disposal Group, Including Discontinued Operation, Revenue | View |
| Due to Related Parties | View |
| Earnings Per Share, Basic | View |
| Earnings Per Share, Basic and Diluted | View |
| Equity Method Investment, Ownership Percentage | View |
| Finite-Lived Intangible Assets, Accumulated Amortization | View |
| Finite-Lived Intangible Asset, Expected Amortization, after Year Five | View |
| Finite-Lived Intangible Asset, Expected Amortization, Year One | View |
| Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | View |
| Finite-Lived Intangible Asset, Expected Amortization, Year Five | View |
| Finite-Lived Intangible Asset, Expected Amortization, Year Four | View |
| Finite-Lived Intangible Asset, Expected Amortization, Year Three | View |
| Gain (Loss) on Investments | View |
| Gain (Loss) on Sale of Investments | View |
| General and Administrative Expense | View |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | View |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | View |
| Income (Loss) from Continuing Operations, Per Basic and Diluted Share | View |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | View |
| Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | View |
| Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | View |
| Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | View |
| Increase (Decrease) in Accounts Payable | View |
| Increase (Decrease) in Accrued Liabilities | View |
| Increase (Decrease) in Prepaid Expense | View |
| Intangible Assets, Net (Excluding Goodwill) | View |
| Operating Leases, Rent Expense | View |
| Liabilities and Equity | View |
| Liabilities, Current | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Net Cash Provided by (Used in) Financing Activities, Continuing Operations | View |
| Net Cash Provided by (Used in) Investing Activities | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Cash Provided by (Used in) Operating Activities, Continuing Operations | View |
| Net Income (Loss) Attributable to Parent | View |
| Net Income (Loss) Available to Common Stockholders, Basic | View |
| Nonoperating Income (Expense) | View |
| Salary and Wage, Officer, Excluding Cost of Good and Service Sold | View |
| Operating Expenses | View |
| Operating Income (Loss) | View |
| Operating Loss Carryforwards | View |
| Operating Loss Carryforwards, Valuation Allowance | View |
| Other Income | View |
| Payments for Rent | View |
| Payments of Stock Issuance Costs | View |
| Preferred Stock, Par or Stated Value Per Share | View |
| Preferred Stock, Shares Authorized | View |
| Prepaid Expense, Current | View |
| Prepaid Expense, Noncurrent | View |
| Proceeds from Issuance of Common Stock | View |
| Proceeds from Issuance or Sale of Equity | View |
| Proceeds from Sale of Equity Method Investments | View |
| Professional Fees | View |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | View |
| Research and Development Expense | View |
| Retained Earnings (Accumulated Deficit) | View |
| Share-based Payment Arrangement, Noncash Expense | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | View |
| Stockholders' Equity Attributable to Parent | View |
| Stock Issued During Period, Shares, New Issues | View |
| Stock Issued During Period, Value, New Issues | View |
| Transfer to Investments | View |
| Weighted Average Number of Shares Outstanding, Diluted | View |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | View |
| Weighted Average Number of Shares Outstanding, Basic | View |
| Other Nonoperating Income | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | View |
| Shares, Issued | View |
| Additional Paid in Capital, Common Stock | View |
| Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units | View |
| Conversion of Stock, Shares Issued | View |
| Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | View |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | View |
| Net Income (Loss) Available to Common Stockholders, Diluted | View |
| Royalty Expense | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | View |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | View |
| Cash | View |
| Increase (Decrease) in Accounts Payable, Related Parties | View |
| Adjustments to Additional Paid in Capital, Other | View |
| Class of Warrant or Right, Exercise Price of Warrants or Rights | View |
| Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | View |
| Preferred Stock Dividends and Other Adjustments | View |
| Proceeds from Warrant Exercises | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | View |
| Stock Issued During Period, Value, Other | View |
| Amortization of Intangible Assets | View |
| Deferred Offering Costs | View |
| Convertible Notes Payable, Current | View |
| Debt Instrument, Fair Value Disclosure | View |
| Debt Instrument, Fee Amount | View |
| Income Taxes Paid, Net | View |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | View |
| Proceeds from Issuance of Private Placement | View |
| Proceeds from Notes Payable | View |
| Proceeds from Other Short-term Debt | View |
| Cash, FDIC Insured Amount | View |
| Debt Conversion, Converted Instrument, Shares Issued | View |
| Debt Instrument, Annual Principal Payment | View |
| Debt Instrument, Face Amount | View |
| Interest Expense, Debt | View |
| 314416 | View |
| Proceeds from (Repayments of) Notes Payable | View |
| Stock Issued | View |
| Stock Issued During Period, Value, Conversion of Convertible Securities | View |
| Gain (Loss) on Extinguishment of Debt | View |
| Increase (Decrease) in Notes Payable, Current | View |
| Repayments of Short-term Debt | View |
| Proceeds from Convertible Debt | View |
| Short-term Bank Loans and Notes Payable | View |
| Short-term Non-bank Loans and Notes Payable | View |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | View |
| Finite-Lived Intangible Asset, Expected Amortization, Year Two | View |
| Finite-Lived Intangible Assets, Net | View |
| Finite-Lived Patents, Gross | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | View |
| Increase (Decrease) in Accounts Payable, Trade | View |
| Goodwill, Impairment Loss | View |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | View |
| Income (Loss) from Equity Method Investments | View |
| Accounts Payable, Trade, Current | View |
| Amortization of Debt Discount (Premium) | View |
| Amortization of Debt Issuance Costs and Discounts | View |